APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brompheniramine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Brompheniramine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchBrompheniramine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Brompheniramine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Brompheniramine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brompheniramine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Brompheniramine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Brompheniramine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brompheniramine include AMAG Pharmaceuticals, Endo International, Eon Pharma, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, PAI, Tanta Pharmaceuticals and USL Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brompheniramine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brompheniramine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brompheniramine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brompheniramine market size, projected growth trends, production technologies, key applications, and end-use industries.

Brompheniramine Segment by Company

AMAG Pharmaceuticals

Endo International

Eon Pharma

Ivax Pharmaceuticals

Newtron Pharmaceuticals

Nexgen Pharma

PAI

Tanta Pharmaceuticals

USL Pharma

Watson Laboratories

Pfizer

Merck

Novartis

Teva

Brompheniramine Segment by Type

Oral Solution

Tablet

Brompheniramine Segment by Application

Hospital

Drug Store

Brompheniramine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brompheniramine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brompheniramine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brompheniramine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brompheniramine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brompheniramine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Brompheniramine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Brompheniramine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Brompheniramine Industry Trends Table 2. Brompheniramine Industry Drivers Table 3. Brompheniramine Industry Opportunities and Challenges Table 4. Brompheniramine Industry Restraints Table 5. Global Brompheniramine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Brompheniramine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Brompheniramine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Brompheniramine Sales Market Share by Manufacturers Table 9. Global Brompheniramine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Brompheniramine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Brompheniramine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Brompheniramine Manufacturers, Product Type & Application Table 13. Global Brompheniramine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Brompheniramine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Solution Table 17. Major Manufacturers of Tablet Table 18. Global Brompheniramine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Brompheniramine Sales by Type (2021-2026) & (K Units) Table 20. Global Brompheniramine Sales by Type (2027-2032) & (K Units) Table 21. Global Brompheniramine Sales Market Share by Type (2021-2026) Table 22. Global Brompheniramine Sales Market Share by Type (2027-2032) Table 23. Global Brompheniramine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Brompheniramine Revenue by Type (2021-2026) & (K Units) Table 25. Global Brompheniramine Revenue by Type (2027-2032) & (K Units) Table 26. Global Brompheniramine Revenue Market Share by Type (2021-2026) Table 27. Global Brompheniramine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Global Brompheniramine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Brompheniramine Sales by Application (2021-2026) & (K Units) Table 32. Global Brompheniramine Sales by Application (2027-2032) & (K Units) Table 33. Global Brompheniramine Sales Market Share by Application (2021-2026) Table 34. Global Brompheniramine Sales Market Share by Application (2027-2032) Table 35. Global Brompheniramine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Brompheniramine Revenue by Application (2021-2026) & (K Units) Table 37. Global Brompheniramine Revenue by Application (2027-2032) & (K Units) Table 38. Global Brompheniramine Revenue Market Share by Application (2021-2026) Table 39. Global Brompheniramine Revenue Market Share by Application (2027-2032) Table 40. Global Brompheniramine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Brompheniramine Sales by Region (2021-2026) & (K Units) Table 42. Global Brompheniramine Sales Market Share by Region (2021-2026) Table 43. Global Brompheniramine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Brompheniramine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Brompheniramine Sales by Country (2021-2026) & (K Units) Table 47. North America Brompheniramine Sales by Country (2027-2032) & (K Units) Table 48. Europe Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Brompheniramine Sales by Country (2021-2026) & (K Units) Table 50. Europe Brompheniramine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Brompheniramine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Brompheniramine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Brompheniramine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Brompheniramine Sales by Country (2027-2032) & (K Units) Table 57. Global Brompheniramine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Brompheniramine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Brompheniramine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Brompheniramine Revenue Market Share by Region (2021-2026) Table 61. Global Brompheniramine Revenue Market Share by Region (2027-2032) Table 62. AMAG Pharmaceuticals Company Information Table 63. AMAG Pharmaceuticals Business Overview Table 64. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AMAG Pharmaceuticals Brompheniramine Product Portfolio Table 66. AMAG Pharmaceuticals Recent Development Table 67. Endo International Company Information Table 68. Endo International Business Overview Table 69. Endo International Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Endo International Brompheniramine Product Portfolio Table 71. Endo International Recent Development Table 72. Eon Pharma Company Information Table 73. Eon Pharma Business Overview Table 74. Eon Pharma Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Eon Pharma Brompheniramine Product Portfolio Table 76. Eon Pharma Recent Development Table 77. Ivax Pharmaceuticals Company Information Table 78. Ivax Pharmaceuticals Business Overview Table 79. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ivax Pharmaceuticals Brompheniramine Product Portfolio Table 81. Ivax Pharmaceuticals Recent Development Table 82. Newtron Pharmaceuticals Company Information Table 83. Newtron Pharmaceuticals Business Overview Table 84. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Newtron Pharmaceuticals Brompheniramine Product Portfolio Table 86. Newtron Pharmaceuticals Recent Development Table 87. Nexgen Pharma Company Information Table 88. Nexgen Pharma Business Overview Table 89. Nexgen Pharma Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Nexgen Pharma Brompheniramine Product Portfolio Table 91. Nexgen Pharma Recent Development Table 92. PAI Company Information Table 93. PAI Business Overview Table 94. PAI Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. PAI Brompheniramine Product Portfolio Table 96. PAI Recent Development Table 97. Tanta Pharmaceuticals Company Information Table 98. Tanta Pharmaceuticals Business Overview Table 99. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Tanta Pharmaceuticals Brompheniramine Product Portfolio Table 101. Tanta Pharmaceuticals Recent Development Table 102. USL Pharma Company Information Table 103. USL Pharma Business Overview Table 104. USL Pharma Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. USL Pharma Brompheniramine Product Portfolio Table 106. USL Pharma Recent Development Table 107. Watson Laboratories Company Information Table 108. Watson Laboratories Business Overview Table 109. Watson Laboratories Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Watson Laboratories Brompheniramine Product Portfolio Table 111. Watson Laboratories Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Pfizer Brompheniramine Product Portfolio Table 116. Pfizer Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Merck Brompheniramine Product Portfolio Table 121. Merck Recent Development Table 122. Novartis Company Information Table 123. Novartis Business Overview Table 124. Novartis Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Novartis Brompheniramine Product Portfolio Table 126. Novartis Recent Development Table 127. Teva Company Information Table 128. Teva Business Overview Table 129. Teva Brompheniramine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Teva Brompheniramine Product Portfolio Table 131. Teva Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Brompheniramine Distributors List Table 135. Brompheniramine Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Brompheniramine Product Image Figure 2. Global Brompheniramine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brompheniramine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brompheniramine Sales (2021-2032) & (K Units) Figure 5. Global Brompheniramine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Brompheniramine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Solution Image Figure 9. Tablet Image Figure 10. Global Brompheniramine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Brompheniramine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Brompheniramine Sales Market Share by Type (2021-2032) Figure 13. Global Brompheniramine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Brompheniramine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Brompheniramine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Global Brompheniramine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Brompheniramine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Brompheniramine Sales Market Share by Application (2021-2032) Figure 21. Global Brompheniramine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Brompheniramine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Brompheniramine Revenue Market Share by Application (2021-2032) Figure 24. North America Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Brompheniramine Sales Market Share by Country (2021-2032) Figure 26. U.S. Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Brompheniramine Sales Market Share by Country (2021-2032) Figure 31. Germany Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Brompheniramine Sales Market Share by Country (2021-2032) Figure 38. China Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Brompheniramine Sales Market Share by Country (2021-2032) Figure 46. Brazil Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Brompheniramine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Brompheniramine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Brompheniramine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Brompheniramine Revenue (2021-2032) & (US$ Million) Figure 57. North America Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Brompheniramine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Brompheniramine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Brompheniramine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Brompheniramine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Brompheniramine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solution
  • Tablet
Applications
  • Hospital
  • Drug Store
Companies covered
  • AMAG Pharmaceuticals
  • Endo International
  • Eon Pharma
  • Ivax Pharmaceuticals
  • Newtron Pharmaceuticals
  • Nexgen Pharma
  • PAI
  • Tanta Pharmaceuticals
  • USL Pharma
  • Watson Laboratories
  • Pfizer
  • Merck
  • Novartis
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brompheniramine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brompheniramine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Brompheniramine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Brompheniramine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Brompheniramine Market Dynamics
  1. 2.1 Brompheniramine Industry Trends
  2. 2.2 Brompheniramine Industry Drivers
  3. 2.3 Brompheniramine Industry Opportunities and Challenges
  4. 2.4 Brompheniramine Industry Restraints
3 Brompheniramine Market by Manufacturers
  1. 3.1 Global Brompheniramine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Brompheniramine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Brompheniramine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Brompheniramine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brompheniramine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Brompheniramine Manufacturers, Product Type & Application
  7. 3.7 Global Brompheniramine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brompheniramine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brompheniramine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brompheniramine Tier 1, Tier 2, and Tier 3
4 Brompheniramine Market by Type
  1. 4.1 Brompheniramine Type Introduction
  2. 4.1.1 Oral Solution
  3. 4.1.2 Tablet
  4. 4.2 Global Brompheniramine Sales by Type
  5. 4.2.1 Global Brompheniramine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brompheniramine Sales by Type (2021-2032)
  7. 4.2.3 Global Brompheniramine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Brompheniramine Revenue by Type
  9. 4.3.1 Global Brompheniramine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Brompheniramine Revenue by Type (2021-2032)
  11. 4.3.3 Global Brompheniramine Revenue Market Share by Type (2021-2032)
5 Brompheniramine Market by Application
  1. 5.1 Brompheniramine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Brompheniramine Sales by Application
  5. 5.2.1 Global Brompheniramine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brompheniramine Sales by Application (2021-2032)
  7. 5.2.3 Global Brompheniramine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Brompheniramine Revenue by Application
  9. 5.3.1 Global Brompheniramine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Brompheniramine Revenue by Application (2021-2032)
  11. 5.3.3 Global Brompheniramine Revenue Market Share by Application (2021-2032)
6 Global Brompheniramine Sales by Region
  1. 6.1 Global Brompheniramine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brompheniramine Sales by Region (2021-2032)
  3. 6.2.1 Global Brompheniramine Sales by Region (2021-2026)
  4. 6.2.2 Global Brompheniramine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Brompheniramine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Brompheniramine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Brompheniramine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Brompheniramine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Brompheniramine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Brompheniramine Revenue by Region
  1. 7.1 Global Brompheniramine Revenue by Region
  2. 7.1.1 Global Brompheniramine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Brompheniramine Revenue by Region (2021-2026)
  4. 7.1.3 Global Brompheniramine Revenue by Region (2027-2032)
  5. 7.1.4 Global Brompheniramine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Brompheniramine Revenue (2021-2032)
  8. 7.2.2 North America Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Brompheniramine Revenue (2021-2032)
  11. 7.3.2 Europe Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Brompheniramine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Brompheniramine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Brompheniramine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AMAG Pharmaceuticals
  2. 8.1.1 AMAG Pharmaceuticals Company Information
  3. 8.1.2 AMAG Pharmaceuticals Business Overview
  4. 8.1.3 AMAG Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AMAG Pharmaceuticals Brompheniramine Product Portfolio
  6. 8.1.5 AMAG Pharmaceuticals Recent Developments
  7. 8.2 Endo International
  8. 8.2.1 Endo International Company Information
  9. 8.2.2 Endo International Business Overview
  10. 8.2.3 Endo International Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Endo International Brompheniramine Product Portfolio
  12. 8.2.5 Endo International Recent Developments
  13. 8.3 Eon Pharma
  14. 8.3.1 Eon Pharma Company Information
  15. 8.3.2 Eon Pharma Business Overview
  16. 8.3.3 Eon Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eon Pharma Brompheniramine Product Portfolio
  18. 8.3.5 Eon Pharma Recent Developments
  19. 8.4 Ivax Pharmaceuticals
  20. 8.4.1 Ivax Pharmaceuticals Company Information
  21. 8.4.2 Ivax Pharmaceuticals Business Overview
  22. 8.4.3 Ivax Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ivax Pharmaceuticals Brompheniramine Product Portfolio
  24. 8.4.5 Ivax Pharmaceuticals Recent Developments
  25. 8.5 Newtron Pharmaceuticals
  26. 8.5.1 Newtron Pharmaceuticals Company Information
  27. 8.5.2 Newtron Pharmaceuticals Business Overview
  28. 8.5.3 Newtron Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Newtron Pharmaceuticals Brompheniramine Product Portfolio
  30. 8.5.5 Newtron Pharmaceuticals Recent Developments
  31. 8.6 Nexgen Pharma
  32. 8.6.1 Nexgen Pharma Company Information
  33. 8.6.2 Nexgen Pharma Business Overview
  34. 8.6.3 Nexgen Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nexgen Pharma Brompheniramine Product Portfolio
  36. 8.6.5 Nexgen Pharma Recent Developments
  37. 8.7 PAI
  38. 8.7.1 PAI Company Information
  39. 8.7.2 PAI Business Overview
  40. 8.7.3 PAI Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PAI Brompheniramine Product Portfolio
  42. 8.7.5 PAI Recent Developments
  43. 8.8 Tanta Pharmaceuticals
  44. 8.8.1 Tanta Pharmaceuticals Company Information
  45. 8.8.2 Tanta Pharmaceuticals Business Overview
  46. 8.8.3 Tanta Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tanta Pharmaceuticals Brompheniramine Product Portfolio
  48. 8.8.5 Tanta Pharmaceuticals Recent Developments
  49. 8.9 USL Pharma
  50. 8.9.1 USL Pharma Company Information
  51. 8.9.2 USL Pharma Business Overview
  52. 8.9.3 USL Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 USL Pharma Brompheniramine Product Portfolio
  54. 8.9.5 USL Pharma Recent Developments
  55. 8.10 Watson Laboratories
  56. 8.10.1 Watson Laboratories Company Information
  57. 8.10.2 Watson Laboratories Business Overview
  58. 8.10.3 Watson Laboratories Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Watson Laboratories Brompheniramine Product Portfolio
  60. 8.10.5 Watson Laboratories Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Brompheniramine Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Brompheniramine Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Novartis
  74. 8.13.1 Novartis Company Information
  75. 8.13.2 Novartis Business Overview
  76. 8.13.3 Novartis Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novartis Brompheniramine Product Portfolio
  78. 8.13.5 Novartis Recent Developments
  79. 8.14 Teva
  80. 8.14.1 Teva Company Information
  81. 8.14.2 Teva Business Overview
  82. 8.14.3 Teva Brompheniramine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Teva Brompheniramine Product Portfolio
  84. 8.14.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brompheniramine Value Chain Analysis
  2. 9.1.1 Brompheniramine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brompheniramine Production Mode & Process
  6. 9.2 Brompheniramine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brompheniramine Distributors
  9. 9.2.3 Brompheniramine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst